Mike Lantry, 1972
The M softball team (14-6) split two games yesterday in Fullerton, CA.
Against Houston (11-9) Sierra Romero hit a home run but apart from that M was able to bring just one of their 13 other baserunners (9 other hits, 2 walks, 2 HBP) around. Romero had 3 hits and Lauren Sweet, Lyndsay Doyle, and Kelsey Susalla 2 each. Megan Betsa started and had a rough outing, allowing 3 runs on 4 hits, a walk, and an HBP in 1.2 innings. Sara Driesenga finished up and fared better, giving up 2 unearned runs on 5 hits and 2 walks in 4.1 innings. She struck out 3 Cougars.
In contrast, M got some timely hitting against Arizona (20-2), in particular from Sierra Lawrence who had two RBI singles. Haylie Wagner went the distance, allowing 1 walk, 1 HBP, and just 4 hits despite striking out just one Wildcat. The M defense did its job, committing no errors and allowing very few of the numerous balls in play to get through for hits.
Today M goes up against Texas.
I was perusing the SXSW schedule today and saw that the linked event is happening today. It's a discussion of the challenges teams are facing getting people to attend games live when the home experience keeps getting better and better, and what teams can do to improve the in-stadium experience. One of the panelists is Jordan Maleh, Michigan's director of Digital Media.
Are there any MGoBoard members attending SXSW, and could we get a report from this? I doubt anything groundbreaking will be shared, but it will probably be very interesting to see how the speakers see and approach the issues differently. It ties into our ongoing discussions about student and attendence in general, and what our school is doing to combat the problems.
Here's to surviving another long week. Weekend plans?
My wife and I are proud Wolverines and aunt and uncle to a boy who is living with Duchenne Muscular Dystrophy, the leading genetic killer of children. A drug that is currently in clinical trials has stopped the progression of this previously incurable disease in all trial users. However, this drug only addresses one of the genetic mutations that cause DMD.
The petition linked below asks the FDA to approve this drug on an accelerated timeline (normal approval takes four years). Accelerated Approval will help get this drug - and variants of it that help boys with different genetic mutations, like our nephew - to the kids who need it to be available now. For our nephew and thousands of other boys, this could be the difference between life and death.
This petition is part of a larger campaign you can read about here.
Sign the Petition.
Thanks for your attention to this OT issue. We recognize that the size and compassion of this readership is a powerful force.
Here's the article from MLIVE:
It will be good to have him around for the playoff push considering the physical state of Zetterberg and Datsyuk.